Comparison between LGT Business Connextions IPO and Mahamaya Lifesciences IPO.
LGT Business Connextions IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Mahamaya Lifesciences IPO is a SME Bookbuilding proposed to list at BSE SME.
LGT Business Connextions IPO | Mahamaya Lifesciences IPO | |
---|---|---|
Logo | ![]() | ![]() |
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price | Bookbuilding |
Listing At | BSE SME | BSE SME |
Lead Managers | Mark Corporate Advisors Pvt.Ltd. | Oneview Corporate Advisors Pvt.Ltd. |
Registrar | Skyline Financial Services Pvt.Ltd. | Kfin Technologies Ltd. |
Market Maker | Asnani Stock Broker Pvt.Ltd. | |
DRHP | DRHP ![]() | DRHP ![]() |
RHP | ||
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL ![]() |
The total issue size of LGT Business Connextions IPO is up to ₹26.68 Cr whereas the issue size of the Mahamaya Lifesciences IPO is up to ₹0.00 Cr. The final issue price of LGT Business Connextions IPO is ₹107.00 per share and of Mahamaya Lifesciences IPO is .
LGT Business Connextions IPO | Mahamaya Lifesciences IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ||
Issue Price (Upper) | ||
Issue Price (Final) | ₹107.00 per share | |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 1200 shares | |
Fresh Issue Size | 22,30,800 shares | 56,38,800 shares |
Fresh Issue Size (Amount) | up to ₹23.87 Cr | up to ₹0.00 Cr |
OFS Issue Size | 2,62,800 shares | 5,40,000 shares |
OFS Issue Size (Amount) | up to ₹2.81 Cr | up to ₹0.00 Cr |
Issue Size Total | 24,93,600 shares | 61,78,800 shares |
Issue Size Total (Amount) | up to ₹26.68 Cr | up to ₹0.00 Cr |
LGT Business Connextions IPO opens on Aug 19, 2025, while Mahamaya Lifesciences IPO opens on . The closing date of LGT Business Connextions IPO and Mahamaya Lifesciences IPO is Aug 21, 2025, and , respectively.
LGT Business Connextions IPO | Mahamaya Lifesciences IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Aug 19, 2025 | |
Issue Close | Aug 21, 2025 | |
Basis Of Allotment (Tentative) | Aug 22, 2025 | |
Initiation of Refunds (Tentative) | Aug 25, 2025 | |
Credit of Share (Tentative) | Aug 25, 2025 | |
Listing date (Tentative) | Aug 26, 2025 | |
Anchor Lockin End date 1 | ||
Anchor Lockin End date 2 |
LGT Business Connextions IPO P/E ratio is 14.38, as compared to Mahamaya Lifesciences IPO P/E ratio of .
LGT Business Connextions IPO | Mahamaya Lifesciences IPO | |||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financials | EBITDA | Mahamaya Lifesciences Limited Financial Information (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 99.95 | 77.27 | ||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 71.95 | |||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 14.38 | |||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹100.29 Cr. | |||||||||||||||||||||||||||||||||||||||||
ROE | 41.89% | 23.67% | ||||||||||||||||||||||||||||||||||||||||
ROCE | 45.19% | 32.38% | ||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.77 | |||||||||||||||||||||||||||||||||||||||||
EPS | ₹7.44 | |||||||||||||||||||||||||||||||||||||||||
RoNW | 41.89% | 21.16% |
In the LGT Business Connextions IPO Retail Individual Investors (RII) are offered 12,46,800 shares while in Mahamaya Lifesciences IPO retail investors are offered 12,46,800 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in LGT Business Connextions IPO and in Mahamaya Lifesciences IPO.
LGT Business Connextions IPO | Mahamaya Lifesciences IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | 1,32,000 shares | |
QIB | 0 shares | |
NII | 12,46,800 shares | |
RII | 12,46,800 shares | |
Employee | 0 shares | |
Others | ||
Total | 24,93,600 shares |
LGT Business Connextions IPO subscribed 1.25x in total, whereas Mahamaya Lifesciences IPO subscribed .
LGT Business Connextions IPO | Mahamaya Lifesciences IPO | |
---|---|---|
QIB (times) | ||
NII (times) | 0.75x | |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 1.75x | |
Employee (times) | ||
Other (times) | ||
Total (times) | 1.25x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O